Table 2 Univariate association analysis for HCC recurrence
HCC, N = 17 | No HCC, N = 103 | p overall | |
|---|---|---|---|
Age 65 | 0.357 | ||
<65 | 11 (64.7%) | 80 (77.7%) | |
> 65 | 6 (35.3%) | 23 (22.3%) | |
Sex | 0.735 | ||
F | 2 (11.8%) | 20 (19.4%) | |
M | 15 (88.2%) | 83 (80.6%) | |
AFP (ng/ml) | 165 [6.70; 435] | 7.10 [4.00; 39.1] | 0.009 |
Waiting_time (days) | 230 [31.0; 394] | 211 [75.5; 344] | 0.934 |
D (mm) | 43.4 (20.0) | 31.5 (20.6) | 0.035 |
MELD | 1.000 | ||
MELD ≤ 15 | 12 (80.0%) | 59 (72.0%) | |
MELD = 15–30 | 2 (13.3%) | 15 (18.3%) | |
MELD > 30 | 1 (6.67%) | 8 (9.76%) | |
preTreat | 1.000 | ||
No pre-treatment | 6 (35.3%) | 39 (37.9%) | |
Pre-treatment | 11 (64.7%) | 64 (62.1%) | |
N | 0.012 | ||
N = 1 | 1 (12.5%) | 58 (63.0%) | |
N = 1–3 | 5 (62.5%) | 25 (27.2%) | |
N > 3 | 2 (25.0%) | 9 (9.78%) | |
Grade | 0.045 | ||
1 | 0 (0.00%) | 23 (43.4%) | |
2 | 5 (83.3%) | 28 (52.8%) | |
3 | 1 (16.7%) | 2 (3.77%) | |
Asan | < 0.001 | ||
Exceeding | 12 (70.6%) | 23 (22.3%) | |
Fulfilling | 5 (29.4%) | 80 (77.7%) | |
AFP score | < 0.001 | ||
> 2 | 12 (70.6%) | 14 (15.9%) | |
≤ 2 | 5 (29.4%) | 74 (84.1%) | |
MC | 0.001 | ||
Exceeding | 13 (76.5%) | 33 (32.0%) | |
Fulfilling | 4 (23.5%) | 70 (68.0%) | |
UTS | < 0.001 | ||
Exceeding | 13 (76.5%) | 21 (20.4%) | |
Fulfilling | 4 (23.5%) | 82 (79.6%) | |